Thanks @Noddy74, mate I read your question wrong and instead went down the rabbit hole of medical device creation and drug approval. However I’ll ask around at work and get back to you.

Out of interest I contacted a friend who owns an engineering company that makes medical devices and gets them through the FDA and TGA. He had this to say: “In terms of a product to get through the tga generally your talking about a 12 month product development window followed by between 1-2 years to get it through the tga. Products Need to be manufactured by companies with an iso13485 certification but usually the actual company making the device needs this accreditation. Complete development cycle depends on the complexity of the product. If it’s a serious piece of hardware then 2 year min.”

All the information is in https://www.tga.gov.au/how-we-regulate/manufacturing/manufacture-medical-device and they meet 3 times a year, with a nice price tag from 10-250k to get your product in front of them.

When it comes to approval of medicines I noticed a lot of companies people are following here for example #Imugene are drug related. Out of interest because we have been talking about lengths of times for medical companies. Take https://www.imugene.com/clinical-pipeline Cross reference it for time taken and % chance at https://www.fda.gov/patients/drug-development-process/step-3-clinical-research. I feel that there will be a few capital raises yet. Not saying its not going to make a lot of money but it will take longer than we think. Anecdotally from a health economist I know who worked at Roche and Novartis a biologic or immunotherapy drug like this will cost about 1-4 billion to get to market.

too many segues I’m afraid but I’ll get back to you from a NSW health procurement perspective.